PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.370
-0.020 (-1.44%)
At close: Mar 25, 2026, 4:00 PM EDT
1.360
-0.010 (-0.73%)
After-hours: Mar 25, 2026, 4:55 PM EDT

PMV Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-77.74-58.71-68.96-73.32-57.85
Depreciation & Amortization
0.131.141.260.320.31
Stock-Based Compensation
5.928.8712.3810.25.34
Other Adjustments
-2.81-1-5.76-0.391.51
Changes in Accounts Payable
-3.423.340.24-0.390.19
Changes in Accrued Expenses
0.42-2.52.63-1.323.89
Changes in Other Operating Activities
3.92-2.432.561.140.04
Operating Cash Flow
-73.58-51.28-55.66-63.76-46.57
Capital Expenditures
-0.03-0.66-0.96-7.98-1.35
Sale of Property, Plant & Equipment
0.030.25---
Purchases of Investments
-88.2-148.29-220.54-229.2-256.85
Proceeds from Sale of Investments
158.37202.04170.96235.82114.61
Investing Cash Flow
70.1753.35-50.55-1.37-143.58
Issuance of Common Stock
0.510.3135.580.962.02
Net Common Stock Issued (Repurchased)
0.510.3135.580.962.02
Financing Cash Flow
0.510.3135.580.962.02
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.01-0.040.03--
Net Cash Flow
-2.892.35-70.59-64.17-188.13
Free Cash Flow
-73.61-51.94-56.62-71.74-47.92
Free Cash Flow Per Share
-1.40-1.01-1.18-1.57-1.06
Levered Free Cash Flow
-76.72-59.81-63.24-81.55-54.77
Unlevered Free Cash Flow
-82.84-68.16-74.41-85.27-55.24
Updated Mar 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q